NCT01707381View on ClinicalTrials.gov

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Ocular HypertensionOpen Angle Glaucoma
Interventions
DRUG

BOL-303259-X

Topical ophthalmic solution

DRUG

Timolol maleate

Topical ophthalmic solution

Trial Locations (1)

92093

University of California San Diego, La Jolla

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT01707381 - BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter